Even though TMO has gained about 9.4% in just seven weeks and nearing its 52 week high, it remains one of my favorite investments.
Highlighted in this blog on November 22 '10, Thermo Fisher Scientific Inc. Co. (TMO) has performed in a very consistent manner. In my opinion, this one has some steam left and it can conceivably reach the low 60's in the next three months.
Last traded at 56.37, TMO should be considered an outperform/buy candidate.
.
Showing posts with label Thermo Fisher Scientific. Show all posts
Showing posts with label Thermo Fisher Scientific. Show all posts
Sunday, January 09, 2011
Monday, November 22, 2010
TMO is on a Steady Pace
On a day when many securities retreated, TMO went against the grain and kept above it's rising bottom's line.
Thermo Fisher Scientific Inc Co (TMO) provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. In layman's terms, a company in the healthcare industry which provides medical instruments and supplies.
Barring any unforeseen major turn in the market, TMO (now trading at 51.53) is poised to reach the 55 level and beyond within the next six weeks.
Positive aspects of TMO:
1. Chart pattern shows a tendency for the stock price to stay above the rising bottom's line.
2. Consistent uptrend and rebound from the lows of August 31 '10.
3. Good average daily volume of about 2.9 million shares.
4. Earnings per share have increased during the past several years.
5. Forward P/E ratio is at about 12.88.
.
Thermo Fisher Scientific Inc Co (TMO) provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. In layman's terms, a company in the healthcare industry which provides medical instruments and supplies.
Barring any unforeseen major turn in the market, TMO (now trading at 51.53) is poised to reach the 55 level and beyond within the next six weeks.
Positive aspects of TMO:
1. Chart pattern shows a tendency for the stock price to stay above the rising bottom's line.
2. Consistent uptrend and rebound from the lows of August 31 '10.
3. Good average daily volume of about 2.9 million shares.
4. Earnings per share have increased during the past several years.
5. Forward P/E ratio is at about 12.88.
.
Saturday, June 13, 2009
Missed the Move on TMO
On 5/15/09 I followed a false signal on TMO and sold it at a slight loss, since then the stock has moved up and gained 6.75... bad call,bummer!
.
.
Friday, May 15, 2009
TMO Shows Weakness
Latest numbers and chart pattern for Thermo Fisher Scientific Inc. (TMO) have made me revise the assessment for the company's near future performance.
Insider selling, price sinking today below its 50 dma and strong overhead resistance, resulted in my choice to exit a long position in the stock.
Bought at about 37.41 on 2/18/09, selling today at 35.04, near a 6.5% loss in 3 months.
I would say it's time to get out and search for better prospects.
.
Insider selling, price sinking today below its 50 dma and strong overhead resistance, resulted in my choice to exit a long position in the stock.
Bought at about 37.41 on 2/18/09, selling today at 35.04, near a 6.5% loss in 3 months.
I would say it's time to get out and search for better prospects.
.
Wednesday, February 18, 2009
A Look at TMO
Fewer and fewer stocks look promising these days when the markets take wild swings and punish most companies under the sun. Has the investing community taken down some solid stocks? According to the chart and numbers available for TMO, I am inclined to favor a long position in the stock.
Thermo Fisher Scientific, Inc. (TMO) provides analytical instruments, equipment, software, and services for research, manufacture, analysis, discovery, and diagnostics in the pharmaceutical markets.
Increased mutual fund interest, reasonable P/E at 12, good volume (just under 5 million/day), low debt, and high ranking in the sector make this company worth considering. TMO is trading today at 37.41, this may be a good entry point.
.
Thermo Fisher Scientific, Inc. (TMO) provides analytical instruments, equipment, software, and services for research, manufacture, analysis, discovery, and diagnostics in the pharmaceutical markets.
Increased mutual fund interest, reasonable P/E at 12, good volume (just under 5 million/day), low debt, and high ranking in the sector make this company worth considering. TMO is trading today at 37.41, this may be a good entry point.
.
Subscribe to:
Posts (Atom)